SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

ChromaDex Corp. – ‘10-Q’ for 9/30/17 – ‘EX-31.2’

On:  Thursday, 11/9/17, at 4:00pm ET   ·   For:  9/30/17   ·   Accession #:  1654954-17-10302   ·   File #:  1-37752

Previous ‘10-Q’:  ‘10-Q’ on 8/10/17 for 7/1/17   ·   Next:  ‘10-Q’ on 5/10/18 for 3/31/18   ·   Latest:  ‘10-Q’ on 11/8/23 for 9/30/23   ·   7 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/09/17  ChromaDex Corp.                   10-Q        9/30/17   61:5.2M                                   Blueprint/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    625K 
 2: EX-2.2      Asset Purchase Agreement                            HTML    360K 
 3: EX-2.3      Amendment to Asset Purchase Agreement               HTML     32K 
 4: EX-10.2     Fifth Business Financing Modification Agreement     HTML     49K 
 5: EX-31.1     Certification Pursuant to Rule 13A-14(A)/15D-14(A)  HTML     23K 
                Certifications Section 302 of the Sarbanes-Oxly                  
                Act of 2002                                                      
 6: EX-31.2     Certification Pursuant to Rule 13A-14(A)/15D-14(A)  HTML     23K 
                Certifications Section 302 of the Sarbanes-Oxly                  
                Act of 2002                                                      
 7: EX-32       Certificate Pursuant to Section 18 U.S.C. Pursuant  HTML     19K 
                to Section 906 of the Sarbanes-Oxley Act of 2002                 
14: R1          Document and Entity Information                     HTML     43K 
15: R2          Condensed Consolidated Balance Sheets (Unaudited)   HTML    106K 
16: R3          Condensed Consolidated Balance Sheets (Unaudited)   HTML     34K 
                (Parenthetical)                                                  
17: R4          Condensed Consolidated Statements of Operations     HTML    113K 
                (Unaudited)                                                      
18: R5          Condensed Consolidated Statement of Stockholders'   HTML     66K 
                Equity (Unaudited) (Usd $)                                       
19: R6          Condensed Consolidated Statement of Stockholders'   HTML     20K 
                Equity (Usd $) (Parenthetical)                                   
20: R7          Condensed Consolidated Statements of Cash Flows     HTML    120K 
                (Unaudited)                                                      
21: R8          Interim Financial Statements                        HTML     23K 
22: R9          Nature of Business and Liquidity                    HTML     27K 
23: R10         Significant Accounting Policies                     HTML     26K 
24: R11         Earnings Per Share Applicable to Common             HTML     39K 
                Stockholders                                                     
25: R12         Related Party Transactions                          HTML     36K 
26: R13         Discontinued Operations                             HTML     62K 
27: R14         Trade Receivables Allowances                        HTML     23K 
28: R15         Inventories                                         HTML     24K 
29: R16         Employee Share-Based Compensation                   HTML     37K 
30: R17         Stock Issuance                                      HTML     22K 
31: R18         Business Segments                                   HTML    109K 
32: R19         Commitments and Contingencies                       HTML     44K 
33: R20         Other Expense                                       HTML     21K 
34: R21         Significant Accounting Policies (Policies)          HTML     29K 
35: R22         Earnings Per Share Applicable to Common             HTML     38K 
                Stockholders (Tables)                                            
36: R23         Related Party Transactions (Tables)                 HTML     29K 
37: R24         Discontinued Operations (Tables)                    HTML     65K 
38: R25         Trade Receivables Allowances (Tables)               HTML     23K 
39: R26         Inventories (Tables)                                HTML     25K 
40: R27         Employee Share-Based Compensation (Tables)          HTML     34K 
41: R28         Business Segments (Tables)                          HTML    112K 
42: R29         Nature of Business and Liquidity (Details           HTML     43K 
                Narrative)                                                       
43: R30         Earnings Per Share Applicable to Common             HTML     49K 
                Stockholders (Details)                                           
44: R31         Related Party Transactions (Details)                HTML     54K 
45: R32         Related Party Transactions (Details Narrative)      HTML     42K 
46: R33         Discontinued Operations (Details)                   HTML     59K 
47: R34         Discontinued Operations (Details 1)                 HTML     49K 
48: R35         Discontinued Operations (Details 2)                 HTML     38K 
49: R36         Discontinued Operations (Details 3)                 HTML     25K 
50: R37         Trade Receivables Allowances (Details)              HTML     24K 
51: R38         Inventories (Details)                               HTML     35K 
52: R39         Employee Share-Based Compensation (Details)         HTML     73K 
53: R40         Employee Share-Based Compensation (Details 1)       HTML     28K 
54: R41         Employee Share-Based Compensation (Details          HTML     28K 
                Narrative)                                                       
55: R42         Stock Issuance (Details Narrative)                  HTML     25K 
56: R43         Business Segments (Details)                         HTML     67K 
57: R44         Business Segments (Details 1)                       HTML     34K 
58: R45         Other Expense (Details Narrative)                   HTML     22K 
60: XML         IDEA XML File -- Filing Summary                      XML    102K 
59: EXCEL       IDEA Workbook of Financial Reports                  XLSX     57K 
 8: EX-101.INS  XBRL Instance -- cdxc-20170930                       XML   1.08M 
10: EX-101.CAL  XBRL Calculations -- cdxc-20170930_cal               XML    135K 
11: EX-101.DEF  XBRL Definitions -- cdxc-20170930_def                XML    213K 
12: EX-101.LAB  XBRL Labels -- cdxc-20170930_lab                     XML    701K 
13: EX-101.PRE  XBRL Presentations -- cdxc-20170930_pre              XML    504K 
 9: EX-101.SCH  XBRL Schema -- cdxc-20170930                         XSD    118K 
61: ZIP         XBRL Zipped Folder -- 0001654954-17-010302-xbrl      Zip     93K 


‘EX-31.2’   —   Certification Pursuant to Rule 13A-14(A)/15D-14(A) Certifications Section 302 of the Sarbanes-Oxly Act of 2002


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:   C: 
  Blueprint  
 
 
Exhibit 31.2
 
 
 
Certification of the Chief Financial Officer
Pursuant to
Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended,
as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
I, Kevin M. Farr, certify that:
 
1. I have reviewed this Quarterly Report on Form 10−Q of ChromaDex Corporation;
 
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a−15(e) and 15d−15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
Date: November 9, 2017
/s/ KEVIN M. FARR
Kevin M. Farr
Chief Financial Officer
 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:11/9/17424B3,  8-K,  EFFECT
For Period end:9/30/17
 List all Filings 


7 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/03/21  ChromaDex Corp.                   10-Q        9/30/21   62:7.1M                                   Workiva Inc Wde… FA01/FA
 8/03/21  ChromaDex Corp.                   10-Q        6/30/21   62:7.3M                                   Workiva Inc Wde… FA01/FA
 5/06/21  ChromaDex Corp.                   10-Q        3/31/21   63:4.6M                                   Blueprint/FA
 3/23/21  ChromaDex Corp.                   S-3                    3:300K                                   Blueprint/FA
 3/12/21  ChromaDex Corp.                   10-K       12/31/20   98:7.7M                                   Blueprint/FA
11/04/20  ChromaDex Corp.                   10-Q        9/30/20   73:5.7M                                   Blueprint/FA
 8/06/20  ChromaDex Corp.                   10-Q        6/30/20   65:5.2M                                   Blueprint/FA
Top
Filing Submission 0001654954-17-010302   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 6, 2:48:23.1am ET